Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: A Children's Oncology Group report

S. Goldman; L. Smith; J. R. Anderson; S. Perkins; L. Harrison; M. B. Geyer; T. G. Gross; H. Weinstein; S. Bergeron; B. Shiramizu; W. Sanger; M. Barth; J. Zhi; M. S. Cairo

doi:10.1038/leu.2012.255

Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: A Children's Oncology Group report

S. Goldman
, L. Smith
, J. R. Anderson
, S. Perkins
, L. Harrison
, M. B. Geyer
, T. G. Gross
, H. Weinstein
, S. Bergeron
, B. Shiramizu
, W. Sanger
, M. Barth
, J. Zhi
, M. S. Cairo

Pediatrics

Medical City Children's Hospital
University of Nebraska Omaha
University of Utah
New York Medical College
Massachusetts General Hospital
Ohio State University
University of California at Irvine
University of Hawai'i at Mānoa
University of Nebraska Medical Center
Hoffmann-La Roche Inc.

Research output: Contribution to journal › Letter › peer-review

150 Scopus citations

Original language	English
Pages (from-to)	1174-1177
Number of pages	4
Journal	Leukemia
Volume	27
Issue number	5
DOIs	https://doi.org/10.1038/leu.2012.255
State	Published - May 2013

Access to Document

10.1038/leu.2012.255

Cite this

Goldman, S., Smith, L., Anderson, J. R., Perkins, S., Harrison, L., Geyer, M. B., Gross, T. G., Weinstein, H., Bergeron, S., Shiramizu, B., Sanger, W., Barth, M., Zhi, J., & Cairo, M. S. (2013). Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: A Children's Oncology Group report. Leukemia, 27(5), 1174-1177. https://doi.org/10.1038/leu.2012.255

@article{76a7af9022af4282af7a23d78fc1f016,

title = "Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: A Children's Oncology Group report",

author = "S. Goldman and L. Smith and Anderson, \{J. R.\} and S. Perkins and L. Harrison and Geyer, \{M. B.\} and Gross, \{T. G.\} and H. Weinstein and S. Bergeron and B. Shiramizu and W. Sanger and M. Barth and J. Zhi and Cairo, \{M. S.\}",

year = "2013",

month = may,

doi = "10.1038/leu.2012.255",

language = "English",

volume = "27",

pages = "1174--1177",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "5",

}

Goldman, S, Smith, L, Anderson, JR, Perkins, S, Harrison, L, Geyer, MB, Gross, TG, Weinstein, H, Bergeron, S, Shiramizu, B, Sanger, W, Barth, M, Zhi, J & Cairo, MS 2013, 'Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: A Children's Oncology Group report', Leukemia, vol. 27, no. 5, pp. 1174-1177. https://doi.org/10.1038/leu.2012.255

TY - JOUR

T1 - Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma

T2 - A Children's Oncology Group report

AU - Goldman, S.

AU - Smith, L.

AU - Anderson, J. R.

AU - Perkins, S.

AU - Harrison, L.

AU - Geyer, M. B.

AU - Gross, T. G.

AU - Weinstein, H.

AU - Bergeron, S.

AU - Shiramizu, B.

AU - Sanger, W.

AU - Barth, M.

AU - Zhi, J.

AU - Cairo, M. S.

PY - 2013/5

Y1 - 2013/5

UR - https://www.scopus.com/pages/publications/84877619828

U2 - 10.1038/leu.2012.255

DO - 10.1038/leu.2012.255

M3 - Letter

C2 - 22940833

AN - SCOPUS:84877619828

SN - 0887-6924

VL - 27

SP - 1174

EP - 1177

JO - Leukemia

JF - Leukemia

IS - 5

ER -

Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: A Children's Oncology Group report

Access to Document

Other files and links

Fingerprint

Cite this